Triasima Portfolio Management inc. Decreases Stake in Lam Research Corporation $LRCX

Triasima Portfolio Management inc. lessened its stake in Lam Research Corporation (NASDAQ:LRCX) by 12.4% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,293 shares of the semiconductor company’s stock after selling 3,570 shares during the quarter. Lam Research accounts for 1.5% of Triasima Portfolio Management inc.’s investment portfolio, making the stock its 16th largest position. Triasima Portfolio Management inc.’s holdings in Lam Research were worth $10,960,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bayban acquired a new stake in shares of Lam Research during the 4th quarter valued at approximately $26,000. Vermillion Wealth Management Inc. purchased a new position in Lam Research in the 1st quarter valued at approximately $26,000. Cedar Mountain Advisors LLC increased its stake in Lam Research by 242.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock valued at $26,000 after purchasing an additional 85 shares in the last quarter. Mcguire Capital Advisors Inc. acquired a new position in Lam Research during the fourth quarter worth $27,000. Finally, Triumph Capital Management purchased a new stake in Lam Research during the third quarter worth $27,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have weighed in on LRCX shares. BNP Paribas Exane upped their target price on Lam Research from $250.00 to $260.00 and gave the company a “neutral” rating in a report on Thursday, April 23rd. New Street Research boosted their price objective on shares of Lam Research from $235.00 to $280.00 and gave the stock a “neutral” rating in a research report on Monday, April 27th. Bank of America raised their target price on shares of Lam Research from $330.00 to $480.00 and gave the company a “buy” rating in a report on Tuesday, June 23rd. Rothschild & Co Redburn lifted their target price on shares of Lam Research from $305.00 to $420.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $400.00 price target (up from $330.00) on shares of Lam Research in a report on Monday, June 15th. One investment analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $358.47.

Lam Research Stock Performance

Shares of LRCX opened at $307.17 on Thursday. Lam Research Corporation has a 1 year low of $94.11 and a 1 year high of $438.50. The company’s 50 day simple moving average is $339.57 and its 200 day simple moving average is $285.35. The company has a market capitalization of $384.37 billion, a price-to-earnings ratio of 53.33, a PEG ratio of 1.30 and a beta of 1.84. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.69 by $0.13. The firm had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm’s quarterly revenue was up 30.0% on a year-over-year basis. During the same period last year, the company earned $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. On average, sell-side analysts predict that Lam Research Corporation will post 9.32 EPS for the current year.

Insider Buying and Selling at Lam Research

In other Lam Research news, Director Eric Brandt sold 54,500 shares of the company’s stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the transaction, the director directly owned 199,205 shares of the company’s stock, valued at $69,881,114. This represents a 21.48% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the business’s stock in a transaction dated Monday, July 13th. The shares were sold at an average price of $335.00, for a total value of $6,124,470.00. Following the completion of the sale, the director directly owned 87,142 shares of the company’s stock, valued at approximately $29,192,570. This represents a 17.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 80,441 shares of company stock valued at $27,614,296 over the last 90 days. 0.31% of the stock is owned by corporate insiders.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.